4.4 Article

Effects of systematic N-terminus deletions and benzoylations of endogenous RF-amide peptides on NPFF1R, NPFF2R, GPR10, GPR54 and GPR103

期刊

PEPTIDES
卷 71, 期 -, 页码 156-161

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2015.07.016

关键词

RF-amides; NPFF; GPR10; GPR54; GPR103; Kisspeptin; PrRP; 26RFa

资金

  1. Agence National de la Recherche [ANR-06-Neuro-041-01, ANR-08-EBIO-014-01]
  2. Alsace BioValley (Conectus, Pharmadol)
  3. Conseil Regional d'Alsace (Pharmadol)
  4. Communaute Urbaine de Strasbourg (Pharmadol)
  5. ICFRC (Pharmadol)
  6. OSEO (Pharmadol)
  7. Direction Generale des Entreprises (Pharmadol)
  8. French government [LABEX ANR-10-LABX-0034_Medalis]

向作者/读者索取更多资源

Mammalian RF-amide peptides including RF-amide-related peptides-1 and -3, neuropeptides AF and FF, Prolactin releasing peptides, Kisspeptins and RFa peptides are currently considered endogenous peptides for the GPCRs NPFF1R, NPFF2R, GPR10, GPR54 and GPR103, respectively. While NPFF1R and NPFF2R displayed high affinity for all the RF-amide peptides, GPR10, GPR54 and GPR103 only bind their cognate ligands. Through a systematic and sequential N-terminus deletion and benzoylation of either RF-amide neuropeptide (RFRP-3, NPFF, Kp-10, PrRP20, and 26RFa), we report the corresponding impact on affinity and activity towards all the RF-amide receptors (NPFF1R, NPFF2R, GPR10, GPR54 and GPR103). Our results highlight the difficulty to develop selective peptide ligands for GPR10, GPR54 or GPR103 without a modification of the C-terminus RF-amide signature, but open the door to the design of new RF-amide peptides acting as agonist for one receptor and antagonist for another one. (C) 2015 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据